Skip to Main Content
Newsroom
BD & Partnering
Get in Touch
LinkedIn
Editas Medicine Linkedin
Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors
Newsroom
BD & Partnering
Get in Touch
LinkedIn
Purchasing Policy Terms and Conditions
+
-
Editas Newsroom
May
2
Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
May
1
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Apr
22
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting